It’s the economy, stupid: the economic benefits of health spending

Is 2022 the Pharma Industry’s ‘Call of Duty’ Moment?

2022: a year in transition

The Global Pandemic Agreement: Time to Get Serious

Australians now understand there is a 'queue' for new health technologies

The rise of India's pharmaceutical sector

100 Years of Insulin: An Access to Medicines Issue Writ Large

Submission to Australia's National Medicines Policy Review

The 2021 WHO Essential Medicines List: How Pharma Can Turn Challenge into Opportunity

Medicines Australia Strategic Agreement is 'the end of the beginning'

NICE methods review, UK Life Sciences Strategy and the life sciences industry: lessons for Australia

Workers of the world resign!: What if post-pandemic staff refuse to return to the office?

Reaching the sea, the sun and the end - Day 7 C2K

Dust, stars and crocodiles – Days 5 & 6 C2K

The roads, the dust and the crash - days 3 & 4 C2K

Dodgy eyes, taipans and a COVID moment - days 1 & 2 C2K

Stroking my ageing ego: pre-ride training for the C2K

Fair dinkum or collywobbles? Life sciences and the Australia – UK free trade agreement

Opportunities for the Life Science Industry in Australia post-COVID

More risk for government this time around in agreement negotiation